Home » Topics » Regulatory

Regulatory
RSS

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Nov. 2, 2000

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Oct. 27, 2000

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

Remicade recommended for approval in Europe for broader application

Oct. 26, 2000

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Oct. 24, 2000

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...